ChemicalBook > CAS DataBase List > 3-((3R,4S)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile

3-((3R,4S)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile

3-((3R,4S)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile Structure
3-((3R,4S)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile
  • CAS No.1092578-46-5
  • Chemical Name:3-((3R,4S)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile
  • CBNumber:CB62642729
  • Molecular Formula:C16H20N6O
  • Formula Weight:312.3696
  • MOL File:1092578-46-5.mol
3-((3R,4S)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile Property
  • Melting point >108°C (dec.)
  • Density 1.296
  • storage temp. Refrigerator
  • solubility Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly, Heated)
  • form Solid
  • pka 6.04±0.60(Predicted)
  • color Pale Yellow to Yellow
  • FDA UNII B64WR5WNB7
Hazard and Precautionary Statements (GHS)
  • Symbol(GHS)
  • Signal wordDanger
  • Hazard statements H302-H360
  • Precautionary statements P201-P202-P264-P270-P281-P301+P312-P308+P313-P330-P405-P501

3-((3R,4S)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile Chemical Properties,Usage,Production

  • Uses (3R,4S)-Tofacitinib is an enantiopure stereoisomer of the drug, Janus kinase 3(Jak3) inhibitor (CP-690,550) that has been found to inhibit selected members of the STE7 and STE20 subfamily of kinases.
  • Definition ChEBI: (3r,4s)-Tofacitinib is a N-acylpiperidine.
3-((3R,4S)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile Preparation Products And Raw materials
Raw materials
Preparation Products
Global(106)Suppliers
  • Supplier:
    Moxin Chemicals
  • Tel: +8617320513646
  • Email:Anna@molcoo.com
  • Country:China
  • ProdList:9684
  • Advantage:58
  • Supplier:
    Henan Tianfu Chemical Co.,Ltd.
  • Tel:+86-0371-55170693<br/>+86-19937530512
  • Email:info@tianfuchem.com
  • Country:China
  • ProdList:21628
  • Advantage:55
  • Supplier:
    career henan chemical co
  • Tel:+86-0371-86658258<br/>+8613203830695
  • Email:sales@coreychem.com
  • Country:China
  • ProdList:29858
  • Advantage:58
  • Supplier:
    Standardpharm Co. Ltd.
  • Tel:86-714-3992388
  • Email:overseasales1@yongstandards.com
  • Country:United States
  • ProdList:14332
  • Advantage:58
  • Supplier:
    BOC Sciences
  • Tel:+1-631-485-4226
  • Email:inquiry@bocsci.com
  • Country:United States
  • ProdList:19552
  • Advantage:58
  • Supplier:
    TargetMol Chemicals Inc.
  • Tel:+1-781-999-5354<br/>+1-00000000000
  • Email:marketing@targetmol.com
  • Country:United States
  • ProdList:32159
  • Advantage:58
  • Supplier:
    Labnetwork lnc.
  • Tel:+86-27-50766799<br/>+8618062016861
  • Email:contact@labnetwork.com
  • Country:China
  • ProdList:19987
  • Advantage:58
3-((3R,4S)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile Spectrum
1092578-46-5, 3-((3R,4S)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrileRelated Search:
  • 1092578-46-5
  • 076-托法替尼
  • 标准品
  • 高端化学
  • 杂质对照品
  • 托法替尼杂质对照品
  • 对照品-杂质对照品
  • 化学试剂、精细化学品、医药中间体、材料中间体
  • 托法替布杂质TFC3-Z3托法替尼杂质42 5
  • 3-((3R,4S)-4-甲基-3-(甲基(7H-吡咯并[2,3-D]嘧啶-4-基)氨基)哌啶-1-基)-3-氧代丙腈
  • 托法替尼(3R,5S)异构体
  • 非对应异构体CP-733,317
  • 托法替布杂质55
  • (3R,4S)-4-甲基-3-(甲基-7H-吡咯并[2,3-D]嘧啶-4-氨基)-BETA-氧代-1(托法替布杂质)
  • (3R,4S)-4-甲基-3-(甲基-7H-吡咯并[2,3-D]嘧啶-4-基氨基)-Β-氧代1-哌啶丙腈
  • 托法替布杂质A
  • 托法替尼异构体SS
  • 托法替尼杂质A (3R,4S)游离
  • 3R,4S托法替布(托法替布M8非对映异构体A)
  • TOFACITINIB相关化合物28(RAC-TRANS-TOFACITINIB)
  • (3R,4S)-托法替尼
  • 托法替尼-IMZ16
  • 托伐替尼杂质E
  • 托伐替尼杂质A
  • (3R,4S)-4-甲基-3-(甲基-7H-吡咯并[2,3-D]嘧啶-4-氨基)-BETA-氧代-1-哌啶丙腈1092578-46-5
  • 托法替尼杂质340
  • 3托法替尼杂质A
  • 1托法替尼杂质A
  • 托法替布杂质TFB-A
  • 托法替尼杂质ABCDEFGH
  • 混旋托法替尼API杂质
  • 混旋托法替尼API杂质 100MG
  • (3R,4S)-4-甲基-3-(甲基-7H-吡咯并[2,3-D]嘧啶-4-氨基)-BETA-氧代-1-哌啶丙腈
  • 1092578-46-5
  • (3R,4S)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-1-piperidinepropanenitrile
  • (3R,4S)-Tofacitinib (Tofacitinib Impurity)
  • 1-Piperidinepropanenitrile, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, (3R,4S)-
  • Tofatinib Impurity A
  • (3R,4S)-Tofacitinib
  • 3-((3R,4S)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitr
  • Azilsartan medoxomil impurity340
  • Tofacitib impurity A
  • Tofacitinib-14
  • Tofacitinib Impurity A (3R,4S)-Tofacitinib
  • Tofacitinib impurity 10/(3R,4S)-Tofacitinib/3-((3R,4S)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino) piperidin-1-yl)-3-oxopropanenitrile
  • (3R,4S)-4-Methyl-3-(Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-ylaMino)-beta-oxo-1-piperidinepropanenitrile
  • Tofacitinib Impurity A(3R,4S)
  • Tofacitinib IMpurity E
  • RS-tofacitinib citirate
  • 3-((3R,4S)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile